SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?


To: software salesperson who wrote (2803)11/15/2012 9:16:41 PM
From: scaram(o)uche  Respond to of 3202
 
Thanks, Sales.... so, it's a "reasonable speculation" that 110 is J1-selective, and, if that speculation is in fact correct, a five-fold selectivity might be sufficient for consideration.

Heh.

Loved that first Lilly slide the other day, might as well have been labeled "incy leg up".

Wei gave us the bit about TNF agents and improvement in hematocrits.

Best! Rick